Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Supriya Rajanna"'
Autor:
Ceyda Bertram, Jennifer Girard, Manohar Reddy Shambannagari, David N Moravec, Ryan J. Jacobs, Srijayaprakash B. Uppada, Neelu Puri, Gregory M. Botting, Deven Etnyre, Amanda L Stone, Jason T. Fong, Zachary Crees, Supriya Rajanna
Publikováno v:
Cancer Biology & Therapy
Numerous tyrosine kinase inhibitors (TKIs) targeting c-Met are currently in clinical trials for several cancers. Their efficacy is limited due to the development of resistance. The present study aims to elucidate this mechanism of c-Met TKI resistanc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b185f548ab294d593eca4ee68172dd66
https://doi.org/10.4161/cbt.29451
https://doi.org/10.4161/cbt.29451
Autor:
Ichwaku Rastogi, Brian Webb, Brad Foster, Andrew Webb, Gagan Chhabra, Supriya Rajanna, Neelu Puri
Publikováno v:
Biochemical and biophysical research communications. 477(4)
According to currently available estimates from Cancer Research UK, 14.1 million new lung cancer cases were diagnosed and a staggering 8.2 million people worldwide died from lung cancer in 2012. EGFR and c-Met are two tyrosine kinase receptors most c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcaae20487e31e6ea2eb4279f9d3a99c
https://pubmed.ncbi.nlm.nih.gov/27396618
https://pubmed.ncbi.nlm.nih.gov/27396618
Autor:
Neelu Puri, Supriya Rajanna, Mark Frakes, Kory Blank, Amanda L Stone, Kymberly Harrington, Joe Cruz, Ichwaku Rastogi
Publikováno v:
Chemotherapy: Open Access.
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. In early stages of NSCLC tumor development (stage I/II), surgical resection is often performed; however, when the cancer becomes metastatic, chemotherapy is most commonly impl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66583033dee8faabe8761f13466d2121
https://doi.org/10.4172/2167-7700.1000136
https://doi.org/10.4172/2167-7700.1000136
Publikováno v:
Journal of Cancer Science & Therapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d40f0fb0a3069f036f5deaba48bbb580
https://doi.org/10.4172/1948-5956.1000e131
https://doi.org/10.4172/1948-5956.1000e131
Publikováno v:
Cancer Research. 75:347-347
Various tyrosine kinase inhibitors (TKI’s) are approved for the treatment of melanoma, but their efficacies are limited due to development of drug resistance. To analyze the resistance to c-Met inhibitors we used two melanoma cell lines: MU which h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::76e135e4404a82f1e45c399be71576d6
https://doi.org/10.1158/1538-7445.am2015-347
https://doi.org/10.1158/1538-7445.am2015-347